Logo CRSP — CRISPR Therapeutics AG

CRSP — CRISPR Therapeutics AG USA

HealthcareBiotechnology

[[ lastPrice | number : 2]]
[[ refundPrice | number : 2]]
[[ refundPriceP | number : 2]]%
[[ lastDate * 1000 | date:'MMM d, y @h:mm a' ]]
Currency in USD
Key statistics
Basic
Not enough data for Risks (Volatility).
Not enough data for Beta calculations.
Market capital
$9.18B
Employees
410
Money
Not enough data for Earnings per share statistics.
Not enough data for Book Value calculations.
Wall Street price
$158.29
PE Ratio
124.34
Dividends
Volume & Social
Short Ratio
2.09%
Daily Volume
2.40M
Volume
Above average +
Social Rate
Untracked
Social Volume
Untracked
 
Latest CRSP news
[[ item.source ]] - [[ item.pubDate | date:'MMM d, y @ h:mma' ]]
[[ item.description ]]
Invest ideas
3 ideas for buy
$0.32
Earnings are positive
Fundamental signal
Earnings per share are positive
26.70%
Wall Street Higher
Fundamental signal
The price is expected to raise
4.59%
Above SMA 200
Technical signal
The price is above SMA for 200 days period
Invest Ideas — the best way to get insights based on both fundamental and technical data. We analyze company's performance across sector and industry and generate investing ideas for you.
Want to track signal changes?
It's easy to monitor changes in signal with our watchlist. Just add the stock to your watchlist and get daily, weekly and monthly signal changes for the asset.
Similar and Opposite stocks
Most and less correlated stocks. All correllations are calculated for 1 year period. Learn more about correlations.
Income Statement
All numbers in thousands [[fin.date | strtotimestamp | date: 'MMM d, yyyy']]
Revenue
Total Revenue [[fin.totalRevenue / 1000 | number : 0]]
Cost of Revenue [[fin.costOfRevenue / 1000 | number : 0]]
Gross Profit [[fin.grossProfit / 1000 | number : 0]]
Operating Expenses
Research Development [[fin.researchDevelopment / 1000 | number : 0]]
Selling General and Administrative [[fin.sellingGeneralAdministrative / 1000 | number : 0]]
Non Recurring [[fin.nonRecurring / 1000 | number : 0]]
Others [[fin.otherOperatingExpenses / 1000 | number : 0]]
Total Operating Expenses [[fin.totalOperatingExpenses / 1000 | number : 0]]
Operating Income or Loss [[fin.operatingIncome / 1000 | number : 0]]
Income from Continuing Operations
Total Other Income/Expenses Net [[fin.totalOtherIncomeExpenseNet / 1000 | number : 0]]
Earnings Before Interest and Taxes [[fin.ebit / 1000 | number : 0]]
Interest Expense [[fin.interestExpense / 1000 | number : 0]]
Income Before Tax [[fin.incomeBeforeTax / 1000 | number : 0]]
Income Tax Expense [[fin.incomeTaxExpense / 1000 | number : 0]]
Minority Interest [[fin.minorityInterest / 1000 | number : 0]]
Net Income From Continuing Ops [[fin.netIncomeFromContinuingOps / 1000 | number : 0]]
Non-recurring Events
Discontinued Operations [[fin.discontinuedOperations / 1000 | number : 0]]
Extraordinary Items [[fin.extraordinaryItems / 1000 | number : 0]]
Effect Of Accounting Changes [[fin.effectOfAccountingCharges / 1000 | number : 0]]
Other Items [[fin.otherItems / 1000 | number : 0]]
Net Income
Net Income [[fin.netIncome / 1000 | number : 0]]
Net Income Applicable To Common Shares [[fin.netIncomeApplicableToCommonShares / 1000 | number : 0]]
Balance Sheet
All numbers in thousands [[fin.date | strtotimestamp | date: 'MMM d, yyyy']]
Current Assets  
Cash And Cash Equivalents [[fin.cash / 1000 | number : 0]]
Short Term Investments [[fin.shortTermInvestments / 1000 | number : 0]]
Net Receivables [[fin.netReceivables/ 1000 | number : 0]]
Inventory [[fin.inventory/ 1000 | number : 0]]
Other Current Assets [[fin.otherCurrentAssets/ 1000 | number : 0]]
Total Current Assets [[fin.totalCurrentAssets / 1000 | number : 0]]
Long Term Investments [[fin.longTermInvestments / 1000 | number : 0]]
Property Plant and Equipment [[fin.propertyPlantEquipment / 1000 | number : 0]]
Goodwill [[fin.goodWill / 1000 | number : 0]]
Intangible Assets [[fin.intangibleAssets / 1000 | number : 0]]
Other Assets [[fin.otherAssets / 1000 | number : 0]]
Total Assets [[fin.totalAssets / 1000 | number : 0]]
Current Liabilities
Accounts Payable [[fin.accountsPayable / 1000 | number : 0]]
Short/Current Long Term Debt [[fin.shortLongTermDebt / 1000 | number : 0]]
Other Current Liabilities [[fin.otherCurrentLiab / 1000 | number : 0]]
Total Current Liabilities [[fin.totalCurrentLiabilities / 1000 | number : 0]]
Long Term Debt [[fin.longTermDebt / 1000 | number : 0]]
Other Liabilities [[fin.otherLiab / 1000 | number : 0]]
Deferred Long Term Liability Charges [[fin.deferredLongTermLiab / 1000 | number : 0]]
Total Liabilities [[fin.totalLiab / 1000 | number : 0]]
Stockholders' Equity
Common Stock [[fin.commonStock / 1000 | number : 0]]
Retained Earnings [[fin.retainedEarnings / 1000 | number : 0]]
Other Stockholder Equity [[fin.otherStockholderEquity / 1000 | number : 0]]
Total Stockholder Equity [[fin.totalStockholderEquity / 1000 | number : 0]]
Net Tangible Assets [[fin.netTangibleAssets / 1000 | number : 0]]
Cash Flow Statement
All numbers in thousands [[fin.date | strtotimestamp | date: 'MMM d, yyyy']]
Net Income [[fin.netIncome/ 1000 | number : 0]]
Operating Activities, Cash Flows Provided By or Used In
Depreciation [[fin.depreciation / 1000 | number : 0]]
Adjustments To Net Income [[fin.changeToNetincome / 1000 | number : 0]]
Changes In Accounts Receivables [[fin.changeToAccountReceivables / 1000 | number : 0]]
Changes In Liabilities [[fin.changeToLiabilities / 1000 | number : 0]]
Changes In Inventories [[fin.changeToInventory / 1000 | number : 0]]
Changes In Other Operating Activities [[fin.changeToOperatingActivities / 1000 | number : 0]]
Total Cash Flow From Operating Activities [[fin.totalCashFromOperatingActivities / 1000 | number : 0]]
Investing Activities, Cash Flows Provided By or Used In
Capital Expenditures [[fin.capitalExpenditures / 1000 | number : 0]]
Investments [[fin.investments / 1000 | number : 0]]
Other Cash flows from Investing Activities [[fin.otherCashflowsFromInvestingActivities / 1000 | number : 0]]
Total Cash Flows From Investing Activities [[fin.totalCashflowsFromInvestingActivities / 1000 | number : 0]]
Financing Activities, Cash Flows Provided By or Used In
Dividends Paid [[fin.dividendsPaid / 1000 | number : 0]]
Sale Purchase of Stock [[fin.salePurchaseOfStock / 1000 | number : 0]]
Net Borrowings [[fin.netBorrowings / 1000 | number : 0]]
Other Cash Flows from Financing Activities [[fin.otherCashflowsFromFinancingActivities / 1000 | number : 0]]
Total Cash Flows From Financing Activities [[fin.totalCashFromFinancingActivities / 1000 | number : 0]]
Change In Cash and Cash Equivalents [[fin.changeInCash / 1000 | number : 0]]
 

CRISPR Therapeutics AG, a gene editing company, focuses on developing transformative gene-based medicines for serious human diseases. The company develops its products using Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9), a gene editing technology that allows for precise directed changes to genomic DNA. It has a portfolio of therapeutic programs in a range of disease areas, including hemoglobinopathies, oncology, regenerative medicine, and rare diseases. The company's lead product candidate is CTX001, an ex vivo CRISPR gene-edited therapy for treating patients suffering from transfusion-dependent beta thalassemia or severe sickle cell disease in which a patient's hematopoietic stem cells are engineered to produce high levels of fetal hemoglobin in red blood cells. It is also developing CTX110, a donor-derived gene-edited allogeneic CAR-T therapy targeting cluster of differentiation 19 positive malignancies. In addition, the company is developing allogeneic CAR-T programs comprising CTX120 targeting B-cell maturation antigen for the treatment of relapsed or refractory multiple myeloma; and CTX130 for the treatment of solid tumors and hematologic malignancies. Further, it engages in the development of regenerative medicine programs in diabetes; and in vivo and other genetic disease programs to treat glycogen storage disease Ia, Duchenne muscular dystrophy, myotonic dystrophy type 1, and cystic fibrosis. The company has strategic partnerships with Bayer Healthcare LLC, Vertex Pharmaceuticals Incorporated, and ViaCyte, Inc. The company was formerly known as Inception Genomics AG and changed its name to CRISPR Therapeutics AG in April 2014. CRISPR Therapeutics AG was incorporated in 2013 and is headquartered in Zug, Switzerland.

Sector: Healthcare
Industry: Biotechnology
Full Time Employees: 410
Avg
-1.52 -6.07 -5.32
High
-1.15 -4.74 -3.67
Low
-1.74 -6.95 -6.38
Avg
1.15M 9.53M 12.1M
High
14.0M 90.0M 90.0M
Low
0 0 0
  [[fin.date | strtotimestamp | date: 'MMM d,yyyy']]
Earnings History
Earnings Actual [[fin.epsActual | number : 2]]
Earnings Estimate [[fin.epsEstimate | number : 2]]
Difference [[fin.epsDifference | number : 2]]
Surprise [[fin.surprisePercent | number : 1]]%
  Cur Qtr ([[financials['etrend']['0q'].date | strtotimestamp | date: 'MMM yyyy']]) Next Qtr ([[financials['etrend']['+1q'].date | strtotimestamp | date: 'MMM yyyy']]) Cur Year ([[financials['etrend']['0y'].date | strtotimestamp | date: 'MMM yyyy']]) Next Year ([[financials['etrend']['+1y'].date | strtotimestamp | date: 'MMM yyyy']])
Earnings Estimate
Number of Analysts [[financials['etrend']['0q'].earningsEstimateNumberOfAnalysts | number : 0]] [[financials['etrend']['+1q'].earningsEstimateNumberOfAnalysts | number : 0]] [[financials['etrend']['0y'].earningsEstimateNumberOfAnalysts | number : 0]] [[financials['etrend']['+1y'].earningsEstimateNumberOfAnalysts | number : 0]]
Estimate Average [[financials['etrend']['0q'].earningsEstimateAvg | number : 2]] [[financials['etrend']['+1q'].earningsEstimateAvg | number : 2]] [[financials['etrend']['0y'].earningsEstimateAvg | number : 2]] [[financials['etrend']['+1y'].earningsEstimateAvg | number : 2]]
Estimate High [[financials['etrend']['0q'].earningsEstimateHigh | number : 2]] [[financials['etrend']['+1q'].earningsEstimateHigh | number : 2]] [[financials['etrend']['0y'].earningsEstimateHigh | number : 2]] [[financials['etrend']['+1y'].earningsEstimateHigh | number : 2]]
Estimate Low [[financials['etrend']['0q'].earningsEstimateLow | number : 2]] [[financials['etrend']['0q'].earningsEstimateLow | number : 2]] [[financials['etrend']['0y'].earningsEstimateLow | number : 2]] [[financials['etrend']['+1y'].earningsEstimateLow | number : 2]]
Estimate Growth [[financials['etrend']['0q'].earningsEstimateGrowth | number : 2]] [[financials['etrend']['+1q'].earningsEstimateGrowth | number : 2]] [[financials['etrend']['0y'].earningsEstimateGrowth | number : 2]] [[financials['etrend']['+1y'].earningsEstimateGrowth | number : 2]]
Year Ago EPS [[financials['etrend']['0q'].earningsEstimateYearAgoEps | number : 2]] [[financials['etrend']['+1q'].earningsEstimateYearAgoEps | number : 2]] [[financials['etrend']['0y'].earningsEstimateYearAgoEps | number : 2]] [[financials['etrend']['+1y'].earningsEstimateYearAgoEps | number : 2]]
All numbers in thousands (except analysts) Cur Qtr ([[financials['etrend']['0q'].date | strtotimestamp | date: 'MMM yyyy']]) Next Qtr ([[financials['etrend']['+1q'].date | strtotimestamp | date: 'MMM yyyy']]) Cur Year ([[financials['etrend']['0y'].date | strtotimestamp | date: 'MMM yyyy']]) Next Year ([[financials['etrend']['+1y'].date | strtotimestamp | date: 'MMM yyyy']])
Revenue Estimate
Number of Analysts [[financials['etrend']['0q'].revenueEstimateNumberOfAnalysts | number : 0]] [[financials['etrend']['+1q'].revenueEstimateNumberOfAnalysts | number : 0]] [[financials['etrend']['0y'].revenueEstimateNumberOfAnalysts | number : 0]] [[financials['etrend']['+1y'].revenueEstimateNumberOfAnalysts | number : 0]]
Estimate Average [[financials['etrend']['0q'].revenueEstimateAvg / 1000 | number : 0]] [[financials['etrend']['+1q'].revenueEstimateAvg / 1000 | number : 0]] [[financials['etrend']['0y'].revenueEstimateAvg / 1000 | number : 0]] [[financials['etrend']['+1y'].revenueEstimateAvg / 1000 | number : 0]]
Estimate High [[financials['etrend']['0q'].revenueEstimateHigh / 1000 | number : 0]] [[financials['etrend']['+1q'].revenueEstimateHigh / 1000 | number : 0]] [[financials['etrend']['0y'].revenueEstimateHigh / 1000 | number : 0]] [[financials['etrend']['+1y'].revenueEstimateHigh / 1000 | number : 0]]
Estimate Low [[financials['etrend']['0q'].revenueEstimateLow / 1000 | number : 0]] [[financials['etrend']['0q'].revenueEstimateLow / 1000 | number : 0]] [[financials['etrend']['0y'].revenueEstimateLow / 1000 | number : 0]] [[financials['etrend']['+1y'].revenueEstimateLow / 1000 | number : 0]]
Estimate Growth [[financials['etrend']['0q'].revenueEstimateGrowth * 100 | number : 2]]% [[financials['etrend']['+1q'].revenueEstimateGrowth * 100 | number : 2]]% [[financials['etrend']['0y'].revenueEstimateGrowth * 100 | number : 2]]% [[financials['etrend']['+1y'].revenueEstimateGrowth * 100| number : 2]]%
Year Ago EPS [[financials['etrend']['0q'].revenueEstimateYearAgoEps | number : 0]] [[financials['etrend']['+1q'].revenueEstimateYearAgoEps | number : 0]] [[financials['etrend']['0y'].revenueEstimateYearAgoEps | number : 0]] [[financials['etrend']['+1y'].revenueEstimateYearAgoEps | number : 0]]
Cur Qtr ([[financials['etrend']['0q'].date | strtotimestamp | date: 'MMM yyyy']]) Next Qtr ([[financials['etrend']['+1q'].date | strtotimestamp | date: 'MMM yyyy']]) Cur Year ([[financials['etrend']['0y'].date | strtotimestamp | date: 'MMM yyyy']]) Next Year ([[financials['etrend']['+1y'].date | strtotimestamp | date: 'MMM yyyy']])
EPS Trend
Current Estimate [[financials['etrend']['0q'].epsTrendCurrent | number : 2]] [[financials['etrend']['+1q'].epsTrendCurrent | number : 2]] [[financials['etrend']['0y'].epsTrendCurrent | number : 2]] [[financials['etrend']['+1y'].epsTrendCurrent | number : 2]]
7 Days Ago [[financials['etrend']['0q'].epsTrend7daysAgo | number : 2]] [[financials['etrend']['+1q'].epsTrend7daysAgo | number : 2]] [[financials['etrend']['0y'].epsTrend7daysAgo| number : 2]] [[financials['etrend']['+1y'].epsTrend7daysAgo | number : 2]]
30 Days Ago [[financials['etrend']['0q'].epsTrend30daysAgo | number : 2]] [[financials['etrend']['+1q'].epsTrend30daysAgo | number : 2]] [[financials['etrend']['0y'].epsTrend30daysAgo | number : 2]] [[financials['etrend']['+1y'].epsTrend30daysAgo | number : 2]]
60 Days Ago [[financials['etrend']['0q'].epsTrend60daysAgo | number : 2]] [[financials['etrend']['+1q'].epsTrend60daysAgo | number : 2]] [[financials['etrend']['0y'].epsTrend60daysAgo | number : 2]] [[financials['etrend']['+1y'].epsTrend60daysAgo | number : 2]]
90 Days Ago [[financials['etrend']['0q'].epsTrend90daysAgo | number : 2]] [[financials['etrend']['+1q'].epsTrend90daysAgo | number : 2]] [[financials['etrend']['0y'].epsTrend90daysAgo | number : 2]] [[financials['etrend']['+1y'].epsTrend90daysAgo | number : 2]]
Cur Qtr ([[financials['etrend']['0q'].date | strtotimestamp | date: 'MMM yyyy']]) Next Qtr ([[financials['etrend']['+1q'].date | strtotimestamp | date: 'MMM yyyy']]) Cur Year ([[financials['etrend']['0y'].date | strtotimestamp | date: 'MMM yyyy']]) Next Year ([[financials['etrend']['+1y'].date | strtotimestamp | date: 'MMM yyyy']])
EPS Revisions
Up Last 7 Days [[financials['etrend']['0q'].epsRevisionsUpLast7days | number : 0]] [[financials['etrend']['+1q'].epsRevisionsUpLast7days | number : 0]] [[financials['etrend']['0y'].epsRevisionsUpLast7days | number : 0]] [[financials['etrend']['+1y'].epsRevisionsUpLast7days | number : 0]]
Up Last 30 Days [[financials['etrend']['0q'].epsRevisionsUpLast30days | number : 0]] [[financials['etrend']['+1q'].epsRevisionsUpLast30days | number : 0]] [[financials['etrend']['0y'].epsRevisionsUpLast30days| number : 0]] [[financials['etrend']['+1y'].epsRevisionsUpLast30days | number : 0]]
Down Last 30 Days [[financials['etrend']['0q'].epsRevisionsDownLast30days | number : 0]] [[financials['etrend']['+1q'].epsRevisionsDownLast30days | number : 0]] [[financials['etrend']['0y'].epsRevisionsDownLast30days | number : 0]] [[financials['etrend']['+1y'].epsRevisionsDownLast30days | number : 0]]
Down Last 90 Days [[financials['etrend']['0q'].epsRevisionsDownLast90days | number : 0]] [[financials['etrend']['+1q'].epsRevisionsDownLast90days | number : 0]] [[financials['etrend']['0y'].epsRevisionsDownLast90days | number : 0]] [[financials['etrend']['+1y'].epsRevisionsDownLast90days | number : 0]]
 
Date Open High Low Close Volume
[[data.Date]] [[data.Open | number : 2]] [[data.High | number : 2]] [[data.Low | number : 2]] [[data.Close | number : 2]] [[data.Volume | number : 0]]